French cosmetic active maker Gattefossé has inaugurated a manufacturing facility dedicated to lipid-based excipients in Lufkin, Texas.
The plant was designed with the dual ambition of increasing production capacity and reinforcing Gattefossé’s presence in North America, a region that is both a leading market and a global trendsetter for pharmaceuticals and personal care.
The inauguration ceremony gathered local and national officials, including Congressman Pete Sessions and Mayor Mark Hicks, alongside Gattefossé executives, customers, partners, employees, and community members.
This major investment represents a pivotal milestone in Gattefossé’s global growth strategy, expanding its production capabilities in North America and reinforcing its position as a top international supplier.
This expansion is also the result of a strong partnership with the City of Lufkin, whose leaders and community have embraced Gattefossé’s vision for sustainable growth.
Congressman Pete Sessions (TX-17) said: “I am proud to welcome Gattefossé to Lufkin. This investment is a testament to the world-class manufacturing capabilities of our workforce and reflects the confidence international companies place in the United States as a strong and reliable partner.”
Lufkin Mayor Mark Hicks added: “Our location between Dallas, Houston, and Shreveport offers strong logistical advantages for industry, while maintaining the small-town values and quality of life that define who we are. This new facility signals momentum, showing that Lufkin is growing, thriving, and competing on a larger scale.”
In March, the Lufkin plant was awarded three world-class certifications - ISO 9001, EFfCI GMP, and EXCiPACT - recognizing Gattefossé’s rigorous approach to quality, safety, and compliance in both pharmaceutical and cosmetic ingredient manufacturing.
In addition to efficiency and performance, the site was designed according to LEED certification criteria, ensuring it meets the highest environmental standards.
Ségolène Moyrand-Gros, President of Gattefossé, said: “The opening of our new plant in Lufkin marks a major milestone in our company’s journey. This investment is not about short-term gain, it is about building a foundation that will serve our customers for decades to come.
“Choosing the United States was a strategic decision: this region is not only a leading market but also a global trendsetter in pharmaceuticals and personal care," she added.
This plant is more than a building; it is a promise to grow, to innovate, and to create value together with confidence, responsibility, and passion.”
